CRBP
Corbus Pharmaceuticals Holdings, Inc. · Healthcare
Chief Executive Officer Yuval Cohen sold $171K of Corbus Pharmaceuticals Holdings, Inc.
Sold$171,396
$10.08Price
17,000Shares
−10%Stake
What CRBP did after the filing
- The stock from Tue, Aug 11 open, $9.54
- −21.9%
- S&P 500, same days
- −0.9%
Measured over 30 trading days, to the Sep 24 close.
Traded Fri, Aug 7. Filed Mon, Aug 10, 4:30 PM ET, after the close. Returns use the Aug 11 open and the Sep 24 close. Not investment advice.